SG184006A1 - Boswellia oil, its fractions and compositions for enhancing brain function - Google Patents

Boswellia oil, its fractions and compositions for enhancing brain function Download PDF

Info

Publication number
SG184006A1
SG184006A1 SG2012067229A SG2012067229A SG184006A1 SG 184006 A1 SG184006 A1 SG 184006A1 SG 2012067229 A SG2012067229 A SG 2012067229A SG 2012067229 A SG2012067229 A SG 2012067229A SG 184006 A1 SG184006 A1 SG 184006A1
Authority
SG
Singapore
Prior art keywords
boswellia
extract
fraction
composition
memory
Prior art date
Application number
SG2012067229A
Other languages
English (en)
Inventor
Ganga Raju Gokaraju
Rama Raju Gokaraju
Venkata Kanaka Ranga Raju Gokaraju
Trimurtulu Golakoti
Kiran Bhupathiraju
Original Assignee
Laila Nutraceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laila Nutraceuticals filed Critical Laila Nutraceuticals
Publication of SG184006A1 publication Critical patent/SG184006A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Plant Substances (AREA)
SG2012067229A 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function SG184006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN687CH2010 IN2010CH00687A (enExample) 2010-03-15 2011-03-14
PCT/IN2011/000170 WO2011114350A2 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function

Publications (1)

Publication Number Publication Date
SG184006A1 true SG184006A1 (en) 2012-10-30

Family

ID=54291846

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012067229A SG184006A1 (en) 2010-03-15 2011-03-14 Boswellia oil, its fractions and compositions for enhancing brain function

Country Status (8)

Country Link
CN (1) CN102811728A (enExample)
AU (2) AU2011228689A1 (enExample)
BR (1) BR112012022983A2 (enExample)
CA (1) CA2793045A1 (enExample)
IN (1) IN2010CH00687A (enExample)
MY (1) MY173288A (enExample)
SG (1) SG184006A1 (enExample)
WO (1) WO2011114350A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG185733A1 (en) * 2010-05-30 2013-01-30 Laila Nutraceuticals Compositions comprising non-acidic boswellia oil fraction as a bio-enhancer for enhancing the bioavailability of biological agents
GB201111319D0 (en) 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
JP6985139B2 (ja) * 2014-10-21 2021-12-22 アルピニア・ローダナム・インスティテュート・オブ・フィトファーマシューティカル・サイエンシーズ・アクチェンゲゼルシャフトAlpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag ボスウェリア属の植物に由来する抽出物、並びに関連する生成物及び使用
WO2016166565A1 (en) * 2015-04-13 2016-10-20 Ethnodyne Use of a withania extract for the treatment of alpha synucleinopathies
CN113855656A (zh) * 2017-05-16 2021-12-31 四川省中医药科学院 四氢姜黄素在制备提高记忆力的药物或保健品中的用途
CN107349190B (zh) * 2017-07-19 2021-04-23 广东工业大学 芳姜黄酮的应用
IT201900013707A1 (it) * 2019-08-01 2021-02-01 Cristalfarma S R L Integratore alimentare, per uso come coadiuvante, per la prevenzione della demenza vascolare
US20230113013A1 (en) 2020-03-03 2023-04-13 Laila Nutrceuticals Synergistic compositions for improving brain health
WO2021205083A2 (fr) 2020-04-11 2021-10-14 Finindsutria Srl Composition pour la prévention ou le traitement du covid-19
CN116370523B (zh) * 2023-04-04 2024-08-13 昆明理工大学 植物精油在制备抗癫痫药物或健康产品中的应用
WO2025177292A1 (en) * 2024-02-21 2025-08-28 Serrata Essentials Pvt. Ltd. A synergistic composition comprising frankincense oil and boswellic acid and a method of making the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer
US7873730B2 (en) * 2003-11-10 2011-01-18 International Business Machines Corporation Method and system for collaborative computing environment access restriction and orphan data management
CN1583063B (zh) * 2004-06-10 2012-03-28 山东齐都药业有限公司 乳香有效成分提取方法及提取物制剂和用途
WO2008036932A2 (en) * 2006-09-21 2008-03-27 Herbalscience Singapore Pte. Ltd. Compositions and methods comprising boswellia species

Also Published As

Publication number Publication date
AU2011228689A1 (en) 2012-09-27
CA2793045A1 (en) 2011-09-22
AU2016201084B2 (en) 2017-10-19
BR112012022983A2 (pt) 2015-09-15
CN102811728A (zh) 2012-12-05
IN2010CH00687A (enExample) 2011-08-31
WO2011114350A3 (en) 2011-11-10
MY173288A (en) 2020-01-13
AU2016201084A1 (en) 2016-03-17
WO2011114350A2 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
AU2016201084B2 (en) Boswellia Oil, Its Fractions And Compositions For Enhancing Brain Function
US9795646B2 (en) Boswellia oil, its fractions and compositions for enhancing brain function
EP2536288B1 (en) A novel boswellia low polar gum resin extract and its synergistic compositions
Ojewole Evaluation of the anti-inflammatory properties of Sclerocarya birrea (A. Rich.) Hochst.(family: Anacardiaceae) stem-bark extracts in rats
Iqubal et al. Current quest in natural bioactive compounds for Alzheimer’s disease: multi-targeted-designed-ligand based approach with preclinical and clinical based evidence
WO2015198346A1 (en) A composition comprising extract of alangium salvifolium having anti-adipogenic or anti-obesic activity
Koynova et al. Natural product formulations for the prevention and treatment of Alzheimer's disease: a patent review
US11071765B2 (en) Herbal compositions comprising extracts of Bacopa monnieri and Terminada chebula
Nandy et al. Bacopa monnieri: The neuroprotective elixir from the East—Phytochemistry, pharmacology, and biotechnological improvement
KR101141439B1 (ko) 생강 또는 건강 추출물을 유효성분으로 함유하는 건망증 및기억력 장애 관련 질환의 예방 및 치료용 조성물
US12194071B2 (en) Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states
KR100890179B1 (ko) 현삼 추출물을 유효성분으로 함유하는 인지기능 장애 관련질환의 예방 및 치료용 조성물
CN102905529B (zh) 含有非酸性乳香油分馏物的组合物作为用于提高生物制剂的生物利用度的生物增强剂
Yuca et al. Matricaria chamomilla L.
US11357810B2 (en) Compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil having synergistic effects for improving memory, focus, and cognitive function, and related methods
KR20040064485A (ko) 아세틸콜린에스터라제 저해 생약 조성물
JP2020508962A (ja) 神経新生の促進を通して脳の健康を改善するための植物抽出物の使用
Uwaya et al. Albizia zygia (DC) Macbr (Fabaceae): A Comparative Investigation of Phytochemical Composition, Proximate Analysis and Anti-Seizure Properties of Methanol Extracts of Its Leaves and Stem-Bark.
Venkata Ratnam et al. Herbal Drugs: Its Mechanism to Prevent Alzheimer’s Disease with Special Reference to Non-phenolic Secondary Metabolites
KR20100014989A (ko) 진저롤을 유효성분으로 함유하는 기억력 및 인지기능 장애관련 질환의 예방 및 치료용 조성물
Hulle et al. Effect of Combination of Polyherbal Extracts for treatment of Hyperlipidemia using Animal Model
KR20230168731A (ko) 침향 추출물을 포함하는 기억력 또는 인지기능 개선용 조성물
Lim Piper methysticum
Abdulkhader et al. Journal of Pharmacy & Allied Medicine
WO2012036506A2 (ko) 기억력 및 학습 능력 증진용 조성물